Cargando…
Somatic pharmacogenomics of gastrointestinal stromal tumor
Gastrointestinal stromal tumors (GISTs) are rare entities, which, however, represent the most common mesenchymal tumor of the gastrointestinal tract. The discovery of gain of function mutations on KIT and PDGFRA receptor genes led to a deep revolution in the knowledge of this tumor. This paved the w...
Autores principales: | Ravegnini, Gloria, Hrelia, Patrizia, Angelini, Sabrina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019173/ https://www.ncbi.nlm.nih.gov/pubmed/35582147 http://dx.doi.org/10.20517/cdr.2019.02 |
Ejemplares similares
-
Personalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA Analysis
por: Ravegnini, Gloria, et al.
Publicado: (2015) -
Clinical relevance of circulating molecules in cancer: focus on gastrointestinal stromal tumors
por: Ravegnini, Gloria, et al.
Publicado: (2019) -
Mechanisms of resistance to a PI3K inhibitor in gastrointestinal stromal tumors: an omic approach to identify novel druggable targets
por: Ravegnini, Gloria, et al.
Publicado: (2019) -
Analysis of microbiome in gastrointestinal stromal tumors: Looking for different players in tumorigenesis and novel therapeutic options
por: Ravegnini, Gloria, et al.
Publicado: (2022) -
Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumors: Small Steps Toward Personalized Medicine?
por: Ravegnini, Gloria, et al.
Publicado: (2019)